X

Raymed Labs Ltd. Stock Analysis

Small Cap
Evaluated by 42 users | BSE: 531207 | NSE: |
Pharmaceuticals & Drugs
Raymed Labs was established in 1994 as a pharmaceutical company with emphasis on injectables with state of the art manufacturing facilities. the company is located at Dehradun Road, Saharanpur, UP. Manufacturing pharmaceutical products, as such, is a specialized job, however, manufacturing of...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Capital Employed 2.24%3.16%-5.1%-9.83%-6.46%-7.11%-9.03%-17.93%-26.65%-35.88%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 0.40.20.20000000
Y-o-Y Gr. Rt.--51.3%0%-100%NANANANANANA
Adjusted EPS (Rs.) 0.020.03-0.09-0.12-0.06-0.04-0.05-0.08-0.09-0.08
Y-o-Y Gr. Rt.-50%-400%NANANANANANANA
Book Value per Share (Rs.) -3.65-3.62-3.74-3.89-4.01-4.05-4.14-4.25-4.39-4.51
Adjusted Net Profit 000-0.1000000
Net Op. Cash Flow (Rs. Cr.) -0.100-0.10.100000
Debt to Cash Flow from Ops -30.17-72.4369.33-43.6317.04-65.75370.4624,433.257,705.291,737.8
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Raymed Labs Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales -100%NANANA
Adjusted EPS -216.7%NANANA
Book Value per Share 0000
Share Price -27.9% -9.6% -16.6% -41%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Equity (%) -0.45-0.912.413.111.41.061.251.891.981.73
Operating Profit Margin (%) 921.19-3.020000000
Net Profit Margin (%) 1.837.24-20.180000000
Debt to Equity -1.43-1.44-1.34-1.29-1.15-1.15-1.12-1.09-1.06-1.04
Working Capital Days 6061,0057430000000
Cash Conversion Cycle 1682602840000000
Entity Percentage Holding
Promoters 28.36%
Institutions 0.96%
Non-Institutions 70.68%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Raymed Labs's performance infers:

Raymed Labs earnings have grown by 0%, whereas share price has depreciated -9.6% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

Data is not available for this company

Raymed Labs was established in 1994 as a pharmaceutical company with emphasis on injectables with state of the art manufacturing facilities. the company is located at Dehradun Road, Saharanpur, UP. Manufacturing pharmaceutical products, as such, is a specialized job, however, manufacturing of injectables is even more difficult since they are normally given during a life saving situation thus their quality standards are much more stringent. Raymed’s quality quickly won

Raymed Labs was established in 1994 as a pharmaceutical company with emphasis on injectables with state of the art manufacturing facilities. the company is located at Dehradun Road, Saharanpur, UP. Manufacturing pharmaceutical products, as such, is a specialized job, however, manufacturing of injectables is even more difficult since they are normally given during a life saving situation thus their quality standards are much more stringent. Raymed’s quality quickly won the trusts of doctors and it established itself as one of the leading quality manufacturers of medicines in the area.

Raymed strives on a well organized management team of skilled and highly trained professionals from different streams.  This team contains chemists, pharmacists, marketing professionals with in-depth knowledge & requirements for human and animal products.

Products range:

  • RAMPICILLIN - Ampicillin, a semisynthetic penicillin
  • RAMPICLOX - Equal quantities of Ampicillin and Cloxacillin
  • RAMPIMOX - Equal quantities of Amoxycillin and Cloxacillin
  • RAMYKACIN - Amikacin Sulphate
  • OXYTETRACYCLINE - The most common Antibiotic in Veterinary Practice
  • RAMYFENAC-Diclofenac Sodium. It is a potent non steroidal Anti-inflammatory, Analgesic & Antipyretic for human use
  • RAMAMINE- Chlorpheniramine Maleate.  The most potent & effective Anti-histaminic for veterinary use
  • RAMYDEX-Dexamethasone Sodium Phosphate. Anti-inflammatory, Anti-allergic, Gluco-corticoid adjuvant with Antibiotic therapy
  • RAMYCIN-Gentamycin Sulphate
  • RAMYPINE - Atropin Sulphate.  The drug has anticholenergic effect in veterinary use.
  • RAMYCHLOR - Chloramphenicol
  • REALOPAR - Paracetamol
  • RAYVIL - Pheniramine Maleate
  • RAMALGIN-P - Phenylbutazone and Analgin with Lignocaine: A unique combination of highly effective analgesic, antispasmodic, anti-inflammatory & Antipyretic for veterinary use.
  • RAMYSCAB - Sulphur with Benzyl Benzoate in Lidocaine base: An ideal treatment of Scabies & other dermal problems in animals
  • RAMYVIT PLEX - Vitamin B1, Vitamin B2, Vitamin B3, Vitamin B12 with Liver Extract:  crude injection and ideal treatment of Scabies & other dermal problems in animals
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback